These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23269783)

  • 1. Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.
    Lindesmith LC; Costantini V; Swanstrom J; Debbink K; Donaldson EF; Vinjé J; Baric RS
    J Virol; 2013 Mar; 87(5):2803-13. PubMed ID: 23269783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.
    Lindesmith LC; Beltramello M; Donaldson EF; Corti D; Swanstrom J; Debbink K; Lanzavecchia A; Baric RS
    PLoS Pathog; 2012; 8(5):e1002705. PubMed ID: 22615565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.
    Debbink K; Lindesmith LC; Donaldson EF; Costantini V; Beltramello M; Corti D; Swanstrom J; Lanzavecchia A; Vinjé J; Baric RS
    J Infect Dis; 2013 Dec; 208(11):1877-87. PubMed ID: 23908476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.
    Lindesmith LC; Donaldson EF; Beltramello M; Pintus S; Corti D; Swanstrom J; Debbink K; Jones TA; Lanzavecchia A; Baric RS
    J Virol; 2014 Aug; 88(16):8826-42. PubMed ID: 24872579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.
    Lindesmith LC; Debbink K; Swanstrom J; Vinjé J; Costantini V; Baric RS; Donaldson EF
    J Virol; 2012 Jan; 86(2):873-83. PubMed ID: 22090098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.
    Lindesmith LC; Kocher JF; Donaldson EF; Debbink K; Mallory ML; Swann EW; Brewer-Jensen PD; Baric RS
    J Infect Dis; 2017 Dec; 216(10):1227-1234. PubMed ID: 28973354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norovirus GII.4 strain antigenic variation.
    Lindesmith LC; Donaldson EF; Baric RS
    J Virol; 2011 Jan; 85(1):231-42. PubMed ID: 20980508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.
    Lindesmith LC; Brewer-Jensen PD; Mallory ML; Yount B; Collins MH; Debbink K; Graham RL; Baric RS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.
    Swanstrom J; Lindesmith LC; Donaldson EF; Yount B; Baric RS
    J Virol; 2014 Jan; 88(2):829-37. PubMed ID: 24173225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.
    Debbink K; Donaldson EF; Lindesmith LC; Baric RS
    J Virol; 2012 Jan; 86(2):1214-26. PubMed ID: 22090110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes.
    Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-host evolution results in antigenically distinct GII.4 noroviruses.
    Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
    J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Norovirus Neutralized by a Monoclonal Antibody Targeting the Histo-Blood Group Antigen Pocket.
    Koromyslova AD; Morozov VA; Hefele L; Hansman GS
    J Virol; 2019 Mar; 93(5):. PubMed ID: 30541855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a blockade epitope of human norovirus GII.17.
    Yi Y; Wang X; Wang S; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Emerg Microbes Infect; 2021 Dec; 10(1):954-963. PubMed ID: 33929932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.
    Parra GI; Abente EJ; Sandoval-Jaime C; Sosnovtsev SV; Bok K; Green KY
    J Virol; 2012 Jul; 86(13):7414-26. PubMed ID: 22532688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
    Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
    J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype distribution of norovirus around the emergence of Sydney_2012 and the antigenic drift of contemporary GII.4 epidemic strains.
    Zhang J; Shen Z; Zhu Z; Zhang W; Chen H; Qian F; Chen H; Wang G; Wang M; Hu Y; Yuan Z
    J Clin Virol; 2015 Nov; 72():95-101. PubMed ID: 26476326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.